Sally Lawrence
Overview
Explore the profile of Sally Lawrence including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sigall Boneh R, Navas-Lopez V, Hussey S, Pujol-Muncunill G, Lawrence S, Rolandsdotter H, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39732356
Background & Aims: The Crohn's disease exclusion diet (CDED) + partial enteral nutrition (PEN) is effective for inducing remission in mild-moderate Crohn's disease (CD). We assessed whether a 2-week course...
2.
Allemang B, Browne M, Barwick M, Bollegala N, Fu N, Lee K, et al.
J Pediatr
. 2024 May;
273:114123.
PMID: 38815748
Objective: To explore the mental health experiences of adolescents and young adults (AYA) with inflammatory bowel disease (IBD) enrolled in a randomized controlled trial evaluating the impact of a multimodal...
3.
Kennedy A, Griffiths A, Muise A, Walters T, Ricciuto A, Huynh H, et al.
Inflamm Bowel Dis
. 2024 May;
30(12):2418-2427.
PMID: 38788739
Background: Patients with inflammatory bowel disease (IBD) exhibit considerable interindividual variability in medication response, highlighting the need for precision medicine approaches to optimize and tailor treatment. Pharmacogenetics (PGx) offers the...
4.
deBruyn J, Huynh H, Griffiths A, Jacobson K, Mack D, Deslandres C, et al.
Am J Gastroenterol
. 2023 Oct;
119(3):565-575.
PMID: 37787642
Introduction: This study compared real-world effectiveness between adalimumab (ADA) and infliximab (IFX) in children with Crohn's disease (CD). Methods: Children enrolled into the prospective Canadian Children Inflammatory Bowel Disease Network...
5.
Dhaliwal J, Tertigas D, Carman N, Lawrence S, deBruyn J, Wine E, et al.
J Crohns Colitis
. 2023 Aug;
18(2):233-245.
PMID: 37602969
Aim: To assess contemporary outcomes in children with acute severe ulcerative colitis [ASUC] at initial presentation. Methods: Between April 2014 and January 2019, children aged <17 years, with new onset...
6.
Foster A, Chan J, Wine E, El-Matary W, Carroll M, Kroeker K, et al.
J Pediatr
. 2023 Apr;
258:113403.
PMID: 37019332
Objectives: To examine readiness of adolescents and young adults (AYAs) with inflammatory bowel disease (IBD) to transition to adult care. Study Design: A cross-sectional multicenter study evaluating transition readiness in...
7.
Jeong J, Walters T, Huynh H, Lawrence S, Mack D, Deslandres C, et al.
Inflamm Bowel Dis
. 2023 Jan;
29(11):1760-1768.
PMID: 36688453
Background: Inflammatory bowel disease (IBD) phenotypes may differ between countries and ancestral groups. The study aim was to examine ancestry and subtype variations of children newly diagnosed with IBD. Methods:...
8.
Lawrence S, Faytrouni F, Harris R, Irvine M, Carrion E, Scott G, et al.
J Pediatr Gastroenterol Nutr
. 2022 Sep;
75(5):601-607.
PMID: 36048178
Objectives: To evaluate the efficacy of standard and optimized infliximab induction dosing in attaining corticosteroid (CS) free clinical remission at week 52 and the effect that post-induction trough levels have...
9.
Eindor-Abarbanel A, Meleady L, Lawrence S, Hamilton Z, Krikler G, Lakhani A, et al.
J Pediatr Gastroenterol Nutr
. 2022 Jul;
75(4):473-479.
PMID: 35815885
Objectives: Limited data are currently available regarding anti-tumor necrosis factor (TNF) use and outcomes in very early onset inflammatory bowel disease (VEOIBD) patients. We aimed to assess the long-term outcomes...
10.
Bollegala N, Barwick M, Fu N, Griffiths A, Keefer L, Ahola Kohut S, et al.
BMC Gastroenterol
. 2022 May;
22(1):251.
PMID: 35585484
Background: Transition in care is defined as the "purposeful and planned movement of adolescents and young adults with a chronic medical condition from pediatric to adult-oriented healthcare systems/care providers." Currently,...